Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5067240019 | Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5067241015 | Product containing bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Bacitracin- and neomycin- and sulfacetamide-containing product | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Product containing sulfacetamide in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Product containing bacitracin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Product containing neomycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has active ingredient | Sulfacetamide (substance) | true | Inferred relationship | Some | 1 | |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has active ingredient | Neomycin (substance) | true | Inferred relationship | Some | 2 | |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has active ingredient | Bacitracin | true | Inferred relationship | Some | 3 | |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) | Is a | True | Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets